Literature DB >> 11897609

In vitro activities of a new des-fluoroquinolone, BMS 284756, and seven other antimicrobial agents against 151 isolates of Eikenella corrodens.

Ellie J C Goldstein1, Diane M Citron, C Vreni Merriam, Yumi A Warren, Kerin L Tyrrell, Helen Fernandez.   

Abstract

The des-fluoroquinolone BMS 284756 was active in vitro against all 151 clinical strains of Eikenella corrodens at a MIC of < or = 0.25 microg/ml and was comparable in activity to moxifloxacin and levofloxacin. The MIC at which 90% of the isolates were inhibited by penicillin G was 2 microg/ml; MICs for 8.6% of the strains (13 of 151) were > or = 4 microg/ml, including for two beta-lactamase-producing isolates. Amoxicillin-clavulanate and ampicillin-sulbactam inhibited all strains at a MIC of < or = 1 microg/ml.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897609      PMCID: PMC127105          DOI: 10.1128/AAC.46.4.1141-1143.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens.

Authors:  E J Goldstein; D M Citron; M Hudspeth; S Hunt Gerardo; C V Merriam
Journal:  J Antimicrob Chemother       Date:  1998-03       Impact factor: 5.790

2.  Eikenella corrodens endocarditis: report of cure in two cases.

Authors:  J E Geraci; P E Hermans; J A Washington
Journal:  Mayo Clin Proc       Date:  1974-12       Impact factor: 7.616

3.  Beta-lactamase-producing Eikenella corrodens in an intraabdominal abscess.

Authors:  E Perez Trallero; J M Garcia Arenzana; G Cilla Eguiluz; J Tovar Larrucea
Journal:  J Infect Dis       Date:  1986-02       Impact factor: 5.226

4.  Characterization of a beta-lactamase-specifying plasmid isolated from Eikenella corrodens and its relationship to a commensal Neisseria plasmid.

Authors:  R Rotger; E García-Valdés; E P Trallero
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

5.  Susceptibility of Eikenella corrodens to newer beta-lactam antibiotics.

Authors:  E J Goldstein; M E Gombert; E O Agyare
Journal:  Antimicrob Agents Chemother       Date:  1980-11       Impact factor: 5.191

6.  Susceptibility of Eikenella corrodens to newer and older quinolones.

Authors:  E J Goldstein; D M Citron; A E Vagvolgyi; M E Gombert
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

7.  Antibiotic susceptibilities of periodontal bacteria. In vitro susceptibilities to eight antimicrobial agents.

Authors:  C B Walker; J D Pappas; K Z Tyler; S Cohen; J M Gordon
Journal:  J Periodontol       Date:  1985-11       Impact factor: 6.993

8.  Pathogenicity of Eikenella corrodens in humans.

Authors:  S Suwanagool; M M Rothkopf; S M Smith; D LeBlanc; R Eng
Journal:  Arch Intern Med       Date:  1983-12

9.  Persistence of associated gram-negative bacteria in experimental actinomycotic lesions in mice.

Authors:  H V Jordan; D M Kelly
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

10.  Prevalence of Eikenella corrodens in dental plaque.

Authors:  E J Goldstein; L A Tarenzi; E O Agyare; J R Berger
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

View more
  2 in total

1.  In vitro activities of tigecycline (GAR-936) and 12 other antimicrobial agents against 90 Eikenella corrodens clinical isolates.

Authors:  Emilia Cercenado; Sonia Cercenado; Emilio Bouza
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

Review 2.  Eikenella corrodens infections in human: Reports of six cases and review of literatures.

Authors:  Li Li; Yu-Bo Shi; Xing-Bei Weng
Journal:  J Clin Lab Anal       Date:  2022-01-12       Impact factor: 2.352

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.